What's in Ferring Ventures Limited's pipeline?

Ferring Ventures Limited has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ferring Ventures Limited's portfolio?

Top competitors by shared drug class: Asker & Baerum Hospital, Chinese University of Hong Kong, Jiangsu XinChen-Techfields Pharma Co., LTD., Laboratorios Silanes S.A. de C.V., Merck Sharp & Dohme LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ferring-ventures-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Ferring Ventures Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ferring Ventures Limited pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Celecoxib Oral Product	Celecoxib Oral Product	phase 3	Selective COX-2 inhibitor (coxib)	COX-2 (Cyclooxygenase-2)	Rheumatology / Pain Management
rAd-IFN	rAd-IFN	phase 3	oncolytic virus		Oncology

Therapeutic area mix

Oncology · 1
Rheumatology / Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Asker & Baerum Hospital · 1 shared drug class
Chinese University of Hong Kong · 1 shared drug class
Jiangsu XinChen-Techfields Pharma Co., LTD. · 1 shared drug class
Laboratorios Silanes S.A. de C.V. · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
National Eye Institute (NEI) · 1 shared drug class
Novartis · 1 shared drug class
Organon and Co · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ferring Ventures Limited:

Cite this brief

Drug Landscape (2026). Ferring Ventures Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ferring-ventures-limited. Accessed 2026-06-10.